| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/15/2005 | EP1539946A1 Methods and compositions for the generation of humanized mice |
| 06/15/2005 | EP1539945A2 Recombinant type ii restriction endonucleases, mmei and related endonucleases and methods for producting the same |
| 06/15/2005 | EP1539944A2 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance |
| 06/15/2005 | EP1539943A2 Method for identifying mhc-presented peptide epitopes for t cells |
| 06/15/2005 | EP1539942A2 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon |
| 06/15/2005 | EP1539941A2 Adzymes and uses thereof |
| 06/15/2005 | EP1539938A1 Chimeric gb virus b (gbv-b) |
| 06/15/2005 | EP1539937A2 Methods for propagating adenovirus and virus produced thereby |
| 06/15/2005 | EP1539932A1 In vitro fertilisation |
| 06/15/2005 | EP1539820A2 Ostertagia vaccine |
| 06/15/2005 | EP1539816A1 Thrombin-cleavable factor x analogues |
| 06/15/2005 | EP1539813A2 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer |
| 06/15/2005 | EP1539809A2 Hcv fusion proteins with modified ns3 domains |
| 06/15/2005 | EP1539808A2 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS |
| 06/15/2005 | EP1539807A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/15/2005 | EP1539805A2 Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer |
| 06/15/2005 | EP1539802A2 Novel kcnq polypeptides, modulators thereof, and their uses in the treatment of mental disorders |
| 06/15/2005 | EP1539794A2 Benzoate- and anthranilate-inducible promoters |
| 06/15/2005 | EP1539793A2 Humanized anti-lymphotoyin beta receptor antibodies |
| 06/15/2005 | EP1539790A2 Method of haplotype-based genetic analysis for determining risk for developing insulin resistance, coronary artery disease and other phenotypes |
| 06/15/2005 | EP1539788A2 METHODS AND COMPOSITIONS FOR USE IN SPLICEOSOME MEDIATED RNA i TRANS /i -SPLICING |
| 06/15/2005 | EP1539786A2 Humanized renilla reniformis green fluorescent protein as a scaffold |
| 06/15/2005 | EP1539785A2 Gene regulation in transgenic animals using a transposon-based vector |
| 06/15/2005 | EP1539784A2 Chitinase encoding dna molecule from cotton expressed preferentially in fibers during secondary cell wall deposition and the corresponding promoter |
| 06/15/2005 | EP1539782A2 A high resolution typing system for pathogenic borrelia |
| 06/15/2005 | EP1539778A2 Deprotection and purification of oligonucleotides and their derivatives |
| 06/15/2005 | EP1539766A1 Calcitonin gene related peptide receptor antagonists |
| 06/15/2005 | EP1539689A2 Antisense modulation of endothelial lipase expression |
| 06/15/2005 | EP1539353A1 Slip cover for heated platen assembly |
| 06/15/2005 | EP1539245A2 Methods and materials for treating human papillomavirus infections |
| 06/15/2005 | EP1539237A2 Humanized antibodies against human 4-1bb |
| 06/15/2005 | EP1539236A2 Compositions, methods and kits relating to anti-platelet autoantibodies and inhibitors thereof |
| 06/15/2005 | EP1539233A1 Super humanized antibodies |
| 06/15/2005 | EP1539228A2 Novel composition and methods for the treatment of immune related diseases |
| 06/15/2005 | EP1539221A2 Transferrin fusion protein libraries |
| 06/15/2005 | EP1539218A2 Compositions and methods for modulating lymphocyte activity |
| 06/15/2005 | EP1539198A2 Lentiviral vector-mediated gene transfer and uses thereof |
| 06/15/2005 | EP1539189A2 Method of using anti-apoptotic factors in gene expression |
| 06/15/2005 | EP1539177A2 Compositions and methods for treating heart disease |
| 06/15/2005 | EP1538904A2 Immunostimulatory nucleic acids |
| 06/15/2005 | EP1538896A1 High yielding soybean plants with increased seed protein plus oil |
| 06/15/2005 | EP1485129A4 Nanostructures containing pilin protein |
| 06/15/2005 | EP1480738B1 Apparatus for treatment of light-sensitive biopolymers |
| 06/15/2005 | EP1474165A4 Thermotolerant phytase for animal feed |
| 06/15/2005 | EP1427842A4 Mid 9002, a human sulfatase family member and uses therefor |
| 06/15/2005 | EP1421187A4 Systems for in vivo site-directed mutagenesis using oligonucleotides |
| 06/15/2005 | EP1383924A4 Lps-responsive chs1/beige-like anchor gene and therapeutic applications thereof |
| 06/15/2005 | EP1322787A4 Bio-chip, photoluminescent methods for identifying biological material, and apparatuses for use with such methods and bio-chips |
| 06/15/2005 | EP1309625B1 Therapeutic compounds for ovarian cancer |
| 06/15/2005 | EP1261641A4 Diagnostic method using expression of mn/ca9 protein in agus pap smears |
| 06/15/2005 | EP1248836B1 Method for preparing vaccines by using hybrid cells |
| 06/15/2005 | EP1212420B1 Conditional immortalisation of cells |
| 06/15/2005 | EP1198255A4 Identification of compounds that modify transcriptional responses to hypoxia |
| 06/15/2005 | EP1180160B1 Antibiotic-based gene regulation system |
| 06/15/2005 | EP1173622B1 Diagnostic sequencing by a combination of specific cleavage and mass spectrometry |
| 06/15/2005 | EP1163340B1 Compositions and methods for the modification of gene expression |
| 06/15/2005 | EP1162955B1 Nanoparticles, complexes with polynucleotides and their use |
| 06/15/2005 | EP1145010B1 Purification process using magnetic particles |
| 06/15/2005 | EP1106692B1 Rna virus vector having contact infiltration capability |
| 06/15/2005 | EP1062348B1 Recombinant onconase and fusion proteins of recombinant onconase |
| 06/15/2005 | EP1015035A4 Vaccination by topical application of genetic vectors |
| 06/15/2005 | EP1012338B1 A tumor suppressor designated ts10q23.3 |
| 06/15/2005 | EP1007713B1 Dna expression in transfected cells and assays carried out in transfected cells |
| 06/15/2005 | EP1005537A4 Nucleic acid molecules specific for bacterial antigens and uses thereof |
| 06/15/2005 | EP0998556B1 Diagnosis and treatment of diseases using anti-t-cell receptor vbeta antibodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein 1 (esrp1) |
| 06/15/2005 | EP0996732B1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants |
| 06/15/2005 | EP0977587B1 Chimeric flavivirus vaccines |
| 06/15/2005 | EP0973380B1 Model for chronic cerebral inflammation by intracerebral injection of polynucleotide |
| 06/15/2005 | EP0954602B1 Hereditary hemochromatosis gene |
| 06/15/2005 | EP0946743B1 A method of enhancing the rate of transfection of cells |
| 06/15/2005 | EP0914344B1 ASSAY AND REAGENTS FOR QUANTIFYING hBNP |
| 06/15/2005 | EP0859057B1 Plasmid |
| 06/15/2005 | EP0837940B1 Ftsy expressing gram-positive microorganisms with enhanced secretion properties |
| 06/15/2005 | EP0815213B1 An immortalized mammal hybridoma fusion partner |
| 06/15/2005 | EP0753061B1 Oral vaccine compositions against infections with yersinia pestis |
| 06/15/2005 | EP0663956B1 Dna sequences which lead to the formation of polyfructans (levans), plasmids containing these sequences as well as a process for preparing transgenic plants |
| 06/15/2005 | CN1628249A Paramycobacterial diagnostics and vaccines |
| 06/15/2005 | CN1628179A Gene and protein relating to hepatocellular carcinoma |
| 06/15/2005 | CN1628177A Method of producing astaxanthin by fermenting selected strains of xanthophyllomyces dendrorhous |
| 06/15/2005 | CN1628176A Methods for large scale protein production in prokaryotes |
| 06/15/2005 | CN1628175A Method for producing methacrylic acid and acrylic acid with a combination of enzyme catalysts |
| 06/15/2005 | CN1628174A Recombination systems and a method for removing nucleic acid sequences from the genome of eukaryotic organisms |
| 06/15/2005 | CN1628173A Rapid and sensitive assay for the detection and quantification of coregulators of nucleic acid binding factors |
| 06/15/2005 | CN1628172A Novel meloidogyne-resistance gene and utilization thereof |
| 06/15/2005 | CN1628171A Separating method and an apparatus performing such a method |
| 06/15/2005 | CN1628170A Environmental stress-responsive promoters and genes encoding transcriptional factor |
| 06/15/2005 | CN1628169A Artificial human chromosome containing human antibody lambda light chain gene |
| 06/15/2005 | CN1628168A Methods and materials for the production of organic products in cells of dollar i(candida) species |
| 06/15/2005 | CN1628167A Interleukin-2 gene transferred lymphokine activated killer cells |
| 06/15/2005 | CN1628128A Mammal prolactin variants |
| 06/15/2005 | CN1628127A Genes from drought stress tolerant tea plant and method of introducing water-stress tolerance |
| 06/15/2005 | CN1628126A Modified transferrin fusion proteins |
| 06/15/2005 | CN1628124A Heteroconfigurational polynucleotide and methods of use |
| 06/15/2005 | CN1626680A Biosensor and method of manufacturing biosensor |
| 06/15/2005 | CN1626679A Methods for assessing and treating cancer |
| 06/15/2005 | CN1626678A Device and method for manufacturing bead array, and method for detecting target substance |
| 06/15/2005 | CN1626677A PCR primer set for detecting hepatitis b virus, method for detecting hepatitis b using the primer set, and hepatitis b virus detection kit including the primer set |
| 06/15/2005 | CN1626674A Assay systems, kits and methods for detecting microorganisms |
| 06/15/2005 | CN1626669A Preparation of full-length human antibody |
| 06/15/2005 | CN1626667A L-glutamic acid-producing bacterium and method for producing L-glutamic acid |